Legato Capital Management »

Taysha Gene Therapies shares owned by Legato Capital Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $83k 15k 5.50

More positions owned by Legato Capital Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Argan (AGX)
Ies Hldgs (IESC)
Alphabet Inc Class A cs (GOOGL)
Stonex Group (SNEX)
Microsoft Corporation (MSFT)
VSE Corporation (VSEC)
Amazon (AMZN)
Agilysys (AGYS)
Triumph Ban (TFIN)
Kratos Defense & Security Solutions (KTOS)
ePlus (PLUS)
UFP Technologies (UFPT)

View all positions for Legato Capital Management

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies